A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.

Jamal, Javeria; O'Loughlin, Aiden; French, John K

Jamal, Javeria; O'Loughlin, Aiden; French, John K.

Jamal J; School of Medicine, Western Sydney University, Sydney, Australia; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia; Liverpool Hospital, Sydney, Australia. Electronic address: 18067343@student.westernsydney.edu.au.
O'Loughlin A; School of Medicine, Western Sydney University, Sydney, Australia.
French JK; School of Medicine, Western Sydney University, Sydney, Australia; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia; Liverpool Hospital, Sydney, Australia.

Int J Cardiol ; 342: 125, 2021 11 01.

Article in English | MEDLINE | ID: covidwho-1330859

Subject(s)

COVID-19; ST Elevation Myocardial Infarction; Fibrinolysis; Humans; SARS-CoV-2; ST Elevation Myocardial Infarction/drug therapy; ST Elevation Myocardial Infarction/therapy; Thrombolytic Therapy

Keywords

COVID-19; Fibrinolysis; Primary percutaneous intervention; ST-segment-elevation myocardial infarction

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: ST Elevation Myocardial Infarction / COVID-19 Limits: Humans Language: English Journal: Int J Cardiol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google